Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 2/20 | 0.54 |
| ▸ | CHRM3 | P20309 | 17/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL783947 | 0.88 | SLC2A1 (0.54) | SLC2A1CHRM3ADRB2CHRM2 | |
| SCHEMBL768571 | 0.84 | CHRM2 (0.54) | SLC2A1CHRM3CHRM2 | |
| SCHEMBL381439 | 0.83 | SLC2A1 (0.48) | SLC2A1CHRM3ADRB2CHRM2 | |
| SCHEMBL381103 | 0.83 | SLC2A1 (0.51) | SLC2A1CHRM3CHRM2 | |
| SCHEMBL769258 | 0.81 | CHRM3 (0.65) | SLC2A1CHRM3 | |
| SCHEMBL381180 | 0.81 | CHRM3 (0.58) | CHRM3 | |
| SCHEMBL4430556 | 0.80 | CHRM3 (0.65) | CHRM3 | |
| SCHEMBL1191081 | 0.80 | CHRM3 (0.65) | CHRM3CHRM2 | |
| SCHEMBL381198 | 0.80 | CHRM3 (0.67) | CHRM3 | |
| SCHEMBL381227 | 0.80 | CHRM3 (0.67) | CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8476253-B2 | Amide derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-07-02 | — | — | US | disclosed |
| US-20120071467-A1 | AMIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-03-22 | — | — | US | disclosed |
| EP-2409977-A1 | AMIDE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2012-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071467-A1 | AMIDE DERIVATIVE | CHRM3, CHRM2, TACR2 | SLC2A1 1942/4885CHRM3 1/4885ADRB2 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.